A patient voice feature on the hope represented with somatostatin analogues in ADPKD
Lanreotide for ADPKD, the Visual Abstract
Divya Bajpai created this week’s visual abstract.
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
Divya Bajpai created this week’s visual abstract.